ArticleJournal of blood medicine2019

Thrombotic events with recombinant activated factor VII (rFVIIa) in approved indications are rare and associated with older age, cardiovascular disease, and concomitant use of activated prothrombin complex concentrates (aPCC).

Madhvi Rajpurkar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.